Taiyen Biotech CoTPE:1737 83 Quick Ratio is 2.48 as of Dec. 2025, which is 19% below its 10-year median of 3.06. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,986 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 79.96% on this metric.
Taiyen Biotech Co has a quick ratio of 2.48. It generally indicates good short-term financial strength.
The historical rank and industry rank for Taiyen Biotech Co's Quick Ratio or its related term are showing as below:
TPE:1737'
s Quick Ratio Range Over the Past 10 Years
Min: 2.15 Med: 3.06 Max: 5.43
Current: 2.48
During the past 13 years, Taiyen Biotech Co's highest Quick Ratio was 5.43. The lowest was 2.15. And the median was 3.06.
TPE:1737's Quick Ratio is ranked better than 79.96% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 1.12
vs TPE:1737: 2.48
Taiyen Biotech Co (TPE:1737) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Taiyen Biotech Co Quick Ratio Related Terms
Taiyen Biotech Co Quick Ratio Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co Quick Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Taiyen Biotech Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiyen Biotech Co (TPE:1737) has a Quick Ratio of 2.48 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Taiyen Biotech Co and its competitors. This is 19% below median its historical median of 3.06. Over the past decade, Taiyen Biotech Co's Quick Ratio has ranged from 2.15 to 5.43. According to the industry distribution chart, Taiyen Biotech Co ranks #398 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 20%.
Is Taiyen Biotech Co's Quick Ratio too high?
Taiyen Biotech Co's current Quick Ratio of 2.48 is 19% below median its 10-year median of 3.06. Over the past 10 years, this metric has ranged from a low of 2.15 to a high of 5.43. The Consumer Packaged Goods industry median Quick Ratio is 1.12. Taiyen Biotech Co's value of 2.48 is 121.4% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #398 out of 1986 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Quick Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #398 out of 1986 companies for Quick Ratio. This places Taiyen Biotech Co in the top 20% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.12. Taiyen Biotech Co's value of 2.48 is 121.4% above this benchmark. Historically, Taiyen Biotech Co's own Quick Ratio has ranged from 2.15 to 5.43 over the past decade. While the company's 10-year median is 3.06 vs. the industry median of 1.12, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Consumer Packaged Goods company?
The median Quick Ratio among Consumer Packaged Goods companies is 1.12, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current Quick Ratio of 2.48 is 121.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Quick Ratio is 1.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current Quick Ratio is 2.48, which is 19% below median its own 10-year median of 3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Quick Ratio is 2.48, which is 19% below median its 10-year median of 3.06 and 121.4% above the Consumer Packaged Goods industry median of 1.12. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Quick Ratio is 2.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
Quick Ratio: 2.48 (19% below median its 10-year median of 3.06)
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 121.4% above the Consumer Packaged Goods median (#398 of 1986)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
